What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Katie Monin, a Seattle lawyer and mother of two young children, chose proton therapy as part of her treatment for brain ...

Dr. Rainer Storb began studying bone marrow transplantation when the field was in its infancy. As he retires 60 years later, ...

It’s a very different world now in cancer,” said longtime patient advocate Ginny Mason. “Now you need to understand the ...

Armstrong, PhD, an assistant professor in the Herbold Computational Biology Program in Fred Hutch’s Public Health Sciences ...

Five years ago, Milton Rubin created the Milton B. Rubin Family Endowed Chair as a means of expressing his gratitude for the ...

Vinh Bui and Tram Le established an endowed chair at Fred Hutch to support lung cancer researcher Dr. David MacPherson ...

Join our first-ever Fred Hutch Giving Day September 17, 2025 as we celebrate 50 years of breakthroughs — in cancer, infectious disease and fundamental research.

The Fred Hutch Lung Cancer Program is the largest, most experienced program of its kind in the Pacific Northwest.

Patient provider profile for Dr. Madhav Dhodapkar, hematologist and medical oncologist at Fred Hutch Cancer Center.

See the latest reports from the Hutchinson Institute for Cancer Outcomes Research (HICOR).

A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.